United Therapeutics Insider Sold Shares Worth $5,309,296, According to a Recent SEC Filing

Martine A Rothblatt, Director, Chairperson & CEO, on July 07, 2026, sold 9,500 shares in United Therapeutics (UTHR) for $5,309,296. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 668,728 common shares of the company, with 40,513 shares held directly and 628,215 controlled indirectly. SEC Filing: